BIOGEN INC. (BIIB) Accrued Income Taxes, Noncurrent USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.
Summary
Biogen Inc. quarterly Accrued Income Taxes, Noncurrent history and growth rate from 2013 to 2024.
  • Biogen Inc. Accrued Income Taxes, Noncurrent for the quarter ending March 31, 2024 was $411M, a 25.6% decline year-over-year.
Accrued Income Taxes, Noncurrent, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $411M -$142M -25.6% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $403M -$139M -25.6% Dec 31, 2023 10-Q 2024-04-24
Q3 2023 $394M -$166M -29.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $383M -$116M -23.3% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 $553M -$88M -13.7% Mar 31, 2023 10-Q 2023-04-25
Q4 2022 $542M -$123M -18.5% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $560M -$97.9M -14.9% Sep 30, 2022 10-Q 2022-10-25
Q2 2022 $500M -$153M -23.5% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $641M -$84.7M -11.7% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $665M -$45.4M -6.4% Dec 31, 2021 10-K 2023-02-15
Q3 2021 $658M -$71.7M -9.83% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $653M -$90.5M -12.2% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $725M -$76.1M -9.5% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $710M -$93.4M -11.6% Dec 31, 2020 10-K 2022-02-03
Q3 2020 $729M -$72.4M -9.03% Sep 30, 2020 10-Q 2020-10-21
Q2 2020 $743M -$58.3M -7.27% Jun 30, 2020 10-Q 2020-07-22
Q1 2020 $801M +$5.2M +0.65% Mar 31, 2020 10-Q 2020-04-23
Q4 2019 $803M +$11.9M +1.5% Dec 31, 2019 10-K 2021-02-03
Q3 2019 $802M +$14.8M +1.88% Sep 30, 2019 10-Q 2019-10-22
Q2 2019 $802M -$12.2M -1.5% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $796M Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $791M -$188M -19.2% Dec 31, 2018 10-K 2020-02-06
Q3 2018 $787M Sep 30, 2018 10-Q 2018-10-23
Q2 2018 $814M Jun 30, 2018 10-Q 2018-07-24
Q4 2017 $980M Dec 31, 2017 10-K 2019-02-06
Q4 2014 $142M -$34.9M -19.7% Dec 31, 2014 10-K 2015-02-04
Q3 2014 $188M Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $199M Jun 30, 2014 10-Q 2014-07-23
Q4 2013 $177M Dec 31, 2013 10-K 2015-02-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.